Acamprosate Calcium Tablet, Delayed Release
Product Images NDC 68462-435

3 FDA label images from Glenmark Pharmaceuticals Inc., Usa · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Acamprosate Calcium (NDC 68462-435). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glenmark Pharmaceuticals Inc., Usa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure.jpg (Structure)

Structure.jpg (Structure)
Chemical structure of Acamprosate Calcium, showing the molecular arrangement including the acetyl, amino, and sulfonate groups complexed with calcium ions (Ca2+).*
FDA Label Image
FDA Label Image

Label333mg180 (Label333mg180)

Label333mg180 (Label333mg180)
Label for Acamprosate Calcium Delayed-Release Tablets, 333 mg strength, containing 180 tablets. The label includes storage instructions, dosage directions, and safety warnings. Distributed by Glenmark Pharmaceuticals Inc., USA, with barcode and contact information for customer questions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.